The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosus
aPL showed an association with fetal loss in SLE, while anti-SSA/Ro antibodies did not. Anti-SSA/Ro may influence fetal development, necessitating further researches.